Rockwell Medical Q1 FY26 net loss widens to $1.6 million; net sales drop 8% to $17.3 million

Rockwell Medical, Inc.

Rockwell Medical, Inc.

RMTI

0.00

  • Rockwell Medical posted Q1 2026 net loss of $1.6 million, widening from year-ago loss of $1.5 million; net sales fell 8% to $17.3 million.
  • Gross margin improved 1 percentage point to 17%, while gross profit held about flat at $2.9 million.
  • Adjusted EBITDA loss narrowed to $0.3 million from $0.4 million.
  • Management said operational changes are expected to generate more than $3 million in additional annualized gross profit, including pricing actions expected to add more than $1 million in annualized revenue and initiatives expected to deliver more than $2 million in annualized savings.
  • 2026 guidance calls for net sales of $70 million-$75 million, gross margin of 18%-22%, adjusted EBITDA of $1 million-$2 million, operating cash flow positive.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rockwell Medical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605070600BIZWIRE_USPR_____20260507_BW118333) on May 07, 2026, and is solely responsible for the information contained therein.